Skip to main content
Cell Death & Disease logoLink to Cell Death & Disease
. 2026 Aug 31;17(1):764. doi: 10.1038/s41419-026-09041-0

Correction: ANP32E drives lung adenocarcinoma progression via GSK3β-mediated glycolytic reprogramming

Zhongliang Wang 1,#, Qianxia Li 2,#, Zeguang Ye 3, Xi Wu 3, Can Fang 3, Wenyang Jiang 4,✉, Min Zhu 3,✉
PMCID: PMC13530245  PMID: 42675050

Correction to: Cell Death & Disease https://doi.org/10.1038/s41419-026-08712-2, published online 14 April 2026

In the original published version of this article, there was a typographical error in the figure legend of Figure 3 regarding the regulation description in panels D and E.

The original sentence read:

“...elevated GSK3β levels with ANP32E overexpression D, E and reduced GSK3β upon ANP32E knockdown F, G.”

The sentence should have read:

“...reduced GSK3β levels with ANP32E overexpression D, E and elevated GSK3β upon ANP32E knockdown F, G.”

The original article has been corrected.

Contributor Information

Wenyang Jiang, Email: whujwy0228@163.com.

Min Zhu, Email: mzhu@tjh.tjmu.edu.cn.


Articles from Cell Death & Disease are provided here courtesy of Nature Publishing Group

RESOURCES